|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roy M, Kung HJ and Ghosh PM: Statins and
prostate cancer: role of cholesterol inhibition vs. prevention of
small GTP-binding proteins. Am J Cancer Res. 1:542–561.
2011.PubMed/NCBI
|
|
3
|
Wang H, Li P and Zhao B: Knockdown of NOB1
expression by RNAi inhibits cellular proliferation and migration in
human gliomas. Gene. 528:146–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated down-regulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar
|
|
5
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Veith T, Martin R, Wurm JP, Weis BL,
Duchardt-Ferner E, Safferthal C, Hennig R, Mirus O, Bohnsack MT,
Wöhnert J and Schleiff E: Structural and functional analysis of the
archaeal endonuclease Nob1. Nucleic Acids Res. 40:3259–3274. 2012.
View Article : Google Scholar :
|
|
7
|
Lu Z, Guo Q, Shi A, Xie F and Lu Q:
Downregulation of NIN/RPN12 binding protein inhibit the growth of
human hepatocellular carcinoma cells. Mol Biol Rep. 39:501–507.
2012. View Article : Google Scholar
|
|
8
|
Huang WY, Chen DH, Ning L and Wang LW:
siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog
inhibits proliferation and growth of breast cancer cells. Asian Pac
J Cancer Prev. 13:1823–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Downregulation of NOB1 suppresses the proliferation and tumor
growth of non-small cell lung cancer in vitro and in vivo. Oncol
Rep. 31:1271–1276. 2014.PubMed/NCBI
|
|
11
|
Che JP, Li W, Yan Y, Liu M, Wang GC, Li
QY, Yang B, Yao XD and Zheng JH: Expression and clinical
significance of the nin one binding protein and p38 MAPK in
prostate carcinoma. Int J Clin Exp Pathol. 6:2300–2311.
2013.PubMed/NCBI
|
|
12
|
Liu G, Shen D, Jiao L and Sun Y: Nin one
binding protein expression as a prognostic marker in prostate
carcinoma. Clin Transl Oncol. 16:843–847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu K, Chen HL, Gu MM and You QS:
Relationship between NOB1 expression and prognosis of resected
non-small cell lung cancer. Int J Biol Markers. 30:e43–e48. 2015.
View Article : Google Scholar
|
|
14
|
Zhang X, Zhang D, Qu F, Hong Y, Cao J, Pan
X, Li L, Huang Y, Huang H, Yin L, et al: Knockdown of NOB1
expression inhibits the malignant transformation of human prostate
cancer cells. Mol Cell Biochem. 396:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ranganathan K and Sivasankar V: MicroRNAs
- Biology and clinical applications. J Oral Maxillofac Pathol.
18:229–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YL, Wu S, Jiang B, Yin FF, Zheng SS
and Hou SC: Role of microRNAs in prostate cancer pathogenesis. Clin
Genitourin Cancer. 13:261–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL, Are C, Brattain M and Wang J: MicroRNA-192 suppresses liver
metastasis of colon cancer. Oncogene. 33:5332–5340. 2014.
View Article : Google Scholar :
|
|
21
|
Jin Y, Lu J, Wen J, Shen Y and Wen X:
Regulation of growth of human bladder cancer by miR-192. Tumour
Biol. 36:3791–3797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goto Y, Kojima S, Nishikawa R, Enokida H,
Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki
N: The microRNA-23b/27b/24-1 cluster is a disease progression
marker and tumor suppressor in prostate cancer. Oncotarget.
5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Augello C, Vaira V, Caruso L, Destro A,
Maggioni M, Park YN, Montorsi M, Santambrogio R, Roncalli M and
Bosari S: MicroRNA profiling of hepatocarcinogenesis identifies
C19MC cluster as a novel prognostic biomarker in hepatocellular
carcinoma. Liver Int. 32:772–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Dong BF, Wang PS, Ren PY, Xue S,
Zhang X, Han Z and Chen G: Silencing NOB1 enhances doxorubicin
antitumor activity of the papillary thyroid carcinoma in vitro and
in vivo. Oncol Rep. 33:1551–1559. 2015.PubMed/NCBI
|
|
25
|
Liu K, Gu MM, Chen HL and You QS: NOB1 in
non-small-cell lung cancer: expression profile and clinical
significance. Pathol Oncol Res. 20:461–466. 2014. View Article : Google Scholar
|
|
26
|
Liu K, Chen HL, Gu MM and You QS: NOB1
expression predicts early response to Cisplatin-based chemotherapy
in patients with advanced non-small cell lung cancer. J Chemother.
May 13–2015.Epub ahead of print. View Article : Google Scholar
|
|
27
|
Chen B, Liu J, Wu D, Qin Y, Peng C, Li C
and Wang J: Gene silencing of NOB1 by lentivirus suppresses growth
and migration of human osteosarcoma cells. Mol Med Rep.
9:2173–2179. 2014.PubMed/NCBI
|
|
28
|
Liu Y, Huang H, Yuan B, Zhuang LY, Luo TP
and Zhang Q: Lentivirus-mediated knockdown of NOB1 suppresses the
proliferation of colon cancer cells. Z Gastroenterol. 52:429–435.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He XW, Feng T, Yin QL, Jian YW and Liu T:
NOB1 is essential for the survival of RKO colorectal cancer cells.
World J Gastroenterol. 21:868–877. 2015.PubMed/NCBI
|
|
30
|
Jia JW, Liu AQ, Wang Y, Zhao F, Jiao LL
and Tan J: Evaluation of NIN/RPN12 binding protein inhibits
proliferation and growth in human renal cancer cells. Tumour Biol.
36:1803–1810. 2015. View Article : Google Scholar
|
|
31
|
Chen J, Wang J, Cui X, Liu Y, Yin L, Li Y,
Chen L, Xu D and Gao Y: Positive nin one binding protein expression
predicts poor outcome in prostate cancer. Mol Med Rep.
11:2671–2676. 2015.
|
|
32
|
Xu YJ and Fan Y: MiR-215/192 participates
in gastric cancer progression. Clin Transl Oncol. 17:34–40. 2015.
View Article : Google Scholar
|
|
33
|
Feinberg-Gorenshtein G, Guedj A, Shichrur
K, Jeison M, Luria D, Kodman Y, Ash S, Feinmesser M, Edry L,
Shomron N, et al: MiR-192 directly binds and regulates Dicer1
expression in neuroblastoma. PLoS One. 8:e787132013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng S, Cong S, Zhang X, Bao X, Wang W, Li
H, Wang Z, Wang G, Xu J, Du B, et al: MicroRNA-192 targeting
retinoblastoma 1 inhibits cell proliferation and induces cell
apoptosis in lung cancer cells. Nucleic Acids Res. 39:6669–6678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang
X, Huang Y, Wang Y, Lu Y, Fu D and Chen J: MicroRNA-326 functions
as a tumor suppressor in glioma by targeting the Nin one binding
protein (NOB1). PLoS One. 8:e684692013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu L, Hui H, Wang LJ, Wang H, Liu QF and
Han SX: MicroRNA-326 functions as a tumor suppressor in colorectal
cancer by targeting the nin one binding protein. Oncol Rep.
33:2309–2318. 2015.PubMed/NCBI
|
|
37
|
Li W, Liu M, Feng Y, Xu YF, Huang YF, Che
JP, Wang GC, Yao XD and Zheng JH: Downregulated miR-646 in clear
cell renal carcinoma correlated with tumour metastasis by targeting
the nin one binding protein (NOB1). Br J Cancer. 111:1188–1200.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li XD, Liu ZY, Chang B, Liu DX, Chen B,
Guo C, Wang YG, Xu JK, Huang DY and Du SX: Panax notoginseng
saponins promote osteogenic differentiation of bone marrow stromal
cells through the ERK and P38 MAPK signaling pathways. Cell Physiol
Biochem. 28:367–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
